BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

For alternative therapies, what is a fair hearing?

Sep. 2, 2014
By Anette Breindl
A paper in the most recent issue of Trends in Molecular Medicine gave a scathing indictment of randomized clinical trials of alternative medicine. Such trials, authors David Gorski of Wayne State University and Stephen Novella of Yale University wrote in their paper "Clinical trials of integrative medicine: testing whether magic works?", have increased tremendously in the past 20 years. And they have not improved medicine overall.
Read More

Researchers alter memories from bad to good and vice versa

Aug. 28, 2014
By Anette Breindl
"Recalling a memory is not like playing a tape recorder," Susumu Tonegawa told reporters. "It is a creative process." Normally, that creativity comes from the organism – man or mouse – doing the remembering. But Tonegawa, who is at the Massachusetts Institute of Technology, and his colleagues have managed to be creative with mouse memories, by altering the association between so-called episodic memories and the emotions that accompanied them.
Read More

Injected vaccine is shot in the arm for polio eradication

Aug. 27, 2014
By Anette Breindl
Polio was declared an eradicable disease in 1988, and although the global polio eradication initiative missed its original goal of wiping the disease off the face of the planet by 2000, it certainly seems possible to get there.
Read More

Deep sequencing reveals mosaic mutations in brain disorders

Aug. 25, 2014
By Anette Breindl
Using deep sequencing of candidate genes, researchers have identified mosaic mutations – mutations that exist in only some of the body's cells, because they arose as a result of a copying error during cell division rather than being present in the sperm or egg – in about a third of patients with malformations of the cerebral cortex.
Read More

Injected vaccine is shot in the arm for polio eradication

Aug. 22, 2014
By Anette Breindl
Polio was declared an eradicable disease in 1988, and although the global polio eradication initiative missed its original goal of wiping the disease off the face of the planet by 2000, it certainly seems possible to get there.
Read More

Experimental drug fights Ebola's cousin Marburg, even after symptom onset

Aug. 21, 2014
By Anette Breindl
Scientists have reported that Tekmira Pharmaceuticals Corp.'s experimental drug candidate TKM-Marburg (NP-718m–LNP) was able to prevent monkeys from becoming seriously ill after Marburg virus infection, even when treatment was not started until the animals showed signs of viremia.
Read More

Antibiotics side effects include later obesity, via gut microbiome

Aug. 19, 2014
By Anette Breindl
One of the biggest side effects of antibiotics may come not at the time of treatment, but years later. Scientists have shown that treatment with antibiotics early in life permanently altered the metabolism of mice, predisposing them to obesity.
Read More

Hopes for HIV cure depends on draining viral reservoir

Aug. 18, 2014
By Anette Breindl
Any HIV-infected person has T cells that are infected with the virus but are not dividing. That so-called quiescent state means that they are not actively contributing to disease, because the virus cannot hijack cellular machinery that is not active in the first place. But it also means they are immune to antiretroviral treatment (ART), which only targets actively dividing virus.
Read More

Send in the 'caveolaery' and solve drug delivery problems

Aug. 18, 2014
By Anette Breindl
Finding a substance with activity against its intended target is only one of the challenges of any therapeutics development effort.
Read More

Part biosurgery, part immunotherapy, C. novyi destroys tumor

Aug. 14, 2014
By Anette Breindl
Researchers have found a way to destroy tumors by directly injecting them with spores of Clostridium novyi, a bacterium that thrives in anaerobic conditions and, therefore, prefers exactly the kind of cancer that other therapies have a hard time getting to: the poorly vascularized core of large tumors.
Read More
View All Articles by Anette Breindl

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Wuxi Apptec signage

    Wuxi Apptec insists it’s ‘not a Chinese military company’

    BioWorld
    Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing